Tech Stock News
Monday, December 5, 2022
Aikido Pharma Inc (NASDAQ: AIKI) gave a piece of information on the progress of its antiviral platform with the University of Maryland School of Medicine. Project on track: As per the Aikido, the project aims to identify and optimize antiviral company, which inhibits viral replication by focusing on a protein […]
Aikido Pharma Inc (NASDAQ: AIKI) announced that the company had filed a provisional patent application to use ketamine and peptides to handle Alzheimer’s disease. The company beforehand protected and announced patent rights for the use of peptides as a drug distribution scheme. This patent request seeks patent defense for the […]